Investigation of effects of a newly discovered type of blood derived stem cell in a mouse model of stroke

Craig Martin McKittrick, Hilary Carswell

Research output: Contribution to conferencePosterpeer-review


Available treatments for ischaemic stroke are limited despite many years of promising research uncovering many potential therapeutic targets. As a result, stroke ranks as the third most common cause of death and the leading cause of major disability worldwide. Stem cells have shown great success in animal models of stroke and are currently in use in clinical trials to treat stroke patients. However, many issues remain unresolved regarding stem cell therapy including tumourigenicity and graft rejection. Here, we evaluate a novel stem cell, known as small pluripotent stem cells, which are readily available from human blood in large numbers and display typical stem cell characteristics, are not immortilised and as an autograft should circumvent graft rejection.
Original languageEnglish
Publication statusPublished - 27 Jun 2013
EventUk Preclinical Stroke Symposium: The advantages and pitfalls of using experimental stroke models - University of Leicester, Leicester, United Kingdom
Duration: 27 Jun 201327 Jun 2013


ConferenceUk Preclinical Stroke Symposium
Country/TerritoryUnited Kingdom
Internet address


  • ischaemic stroke
  • stem cells
  • small pluripotent stem cells

Cite this